Cancers (Jan 2022)

Prevalence and Management of Cancer of the Rectal Stump after Total Colectomy and Rectal Sparing in Patients with Familial Polyposis: Results from a Registry-Based Study

  • Gaia Colletti,
  • Chiara Maura Ciniselli,
  • Stefano Signoroni,
  • Ivana Maria Francesca Cocco,
  • Andrea Magarotto,
  • Maria Teresa Ricci,
  • Clorinda Brignola,
  • Clara Bagatin,
  • Laura Cattaneo,
  • Andrea Mancini,
  • Federica Cavalcoli,
  • Massimo Milione,
  • Paolo Verderio,
  • Marco Vitellaro

DOI
https://doi.org/10.3390/cancers14020298
Journal volume & issue
Vol. 14, no. 2
p. 298

Abstract

Read online

Background: The balance between quality of life and colorectal cancer risk in familial adenomatous polyposis (FAP) patients is of primary importance. A cut-off of less than 30 polyps under 1 cm of diameter in the rectum has been used as an indication for performing ileo-rectal anastomosis (IRA) in terms of lower rectal cancer risk. This study aimed to assess clinical and surgical features of FAP patients who developed cancer of the rectal stump. Methods: This retrospective study included all FAP patients who underwent total colectomy/IRA from 1977 to 2021 and developed subsequent rectal cancer. Patients’ features were reported using descriptive statistics by considering the overall case series and within pre-specified classes of age (30 years) at first surgery. Results: Among the 715 FAP patients, 47 (6.57%, 95% confidence interval: 4.87; 8.65) developed cancer in the rectal stump during follow-up. In total, 57.45% of the population were male and 38.30% were proband. The median interval between surgery and the occurrence of rectal cancer was 13 years. This interval was wider in the youngest group (p-value: 0.012) than the oldest ones. Twelve patients (25.53%) received an endoscopic or minimally invasive resection. Amongst them, 61.70% were Dukes stage A cancers. Conclusions: There is a definite risk of rectal cancer after total colectomy/IRA; however, the time interval from the index procedure to cancer developing is long. Minimally invasive and endoscopic treatments should be the procedures of choice in patients with early stage cancers.

Keywords